Electric mobility, drones, bulk drugs to contribute $170 bn to manufacturing by 2025-26: DIPP working group

NEW DELHI: Biotechnology, electric mobility, unmanned aerial vehicles and bulk drugs are among the eight emerging sectors that will contribute $170 billion to India’s manufacturing gross value added by 2025-26, a working group of the Department of Industrial Policy and Promotion (DIPP) has said.

Medical devices, robotics & automation equipment, advanced materials, and chemicals are the other emerging sectors that the group has identified to play a significant role in manufacturing.

“These sectors have exponential growth potential which need to be explored. Detailed assessment of the potential of these sectors should be taken up and actionable roadmaps drawn up to harness the potential,” said the working group on making India a $5 trillion economy by 2025 in its report.

Focus on emerging sectors is part of the three pronged strategy suggested by the group to achieve $1 trillion from manufacturing. Focus on existing high impact sectors and medium, small and micro enterprises (MSME) are the other two pillars.

Another $1 trillion from is expected to come from agriculture and allied activities while contribution from the services sector is pegged at $3 trillion.

The report has suggested an e-commerce policy and regulatory framework to strengthen the country’s logistics sector and using e-commerce to facilitate access to larger markets both domestic and international.

It said in the defence sector, there is a need to identify key components and systems and encourage global leaders to set up manufacturing base in India by offering limited period incentives; and ensure incentives result in technology/process transfer.

“Where applicable, leverage government purchases (Offset Policy), particularly for technology transfer; and ensure high-quality anchor investors capable of spurring growth of associated suppliers (including MSMEs) and offer limited period incentives to anchors, if required,” it said.

To boost electronics manufacturing, it said the government should consider offering additional fiscal incentives such as a limited-period tax holiday to players investing more than an identified threshold of investment. The report suggested measures to boost manufacturing in other areas including aeronautical, space, garments, organic and ayurvedic products.

Related Posts

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Milan: CPHI Milan 2026, one of the pharmaceutical industry’s largest global events, has launched four specialist zones designed to connect pharmaceutical companies with the technologies, services and expertise shaping the…

Lilly takes 6 companies to court for selling retatrutide knockoffs

Washington: Eli Lilly’s experimental weight-loss drug retatrutide has yet to be approved by the FDA. But the buzz surrounding the effectiveness of the compound—commonly known as triple-G—has already triggered a…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

CPHI Milan launches four special AI, cold chain, contamination control & labelling zones at this year’s event

Lilly takes 6 companies to court for selling retatrutide knockoffs

Lilly takes 6 companies to court for selling retatrutide knockoffs

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

FDA Busts Abortion Medicine Racket in Nagpur, Solapur; IndiaMART Directors among 8 Booked

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

Sun Pharma will Need HC Nod for Semaglutide Tablet Launch